A comprehensive review on the phytochemistry, pharmacokinetics, and antidiabetic effect of Ginseng

人参 植物化学 医学 药代动力学 药理学 传统医学 化学 替代医学 病理
作者
Yage Liu,Hao Zhang,Xuan Dai,Ruyuan Zhu,Beibei Chen,Bingke Xia,Zimengwei Ye,Dandan Zhao,Si‐Hua Gao,Alexander N. Orekhov,Dongwei Zhang,Lili Wang,Shuzhen Guo
出处
期刊:Phytomedicine [Elsevier BV]
卷期号:92: 153717-153717 被引量:52
标识
DOI:10.1016/j.phymed.2021.153717
摘要

Radix Ginseng, one of the well-known medicinal herbs, has been used in the management of diabetes and its complications for more than 1000 years. The aim of this review is devoted to summarize the phytochemistry and pharmacokinetics of Ginseng, and provide evidence for the antidiabetic effects of Ginseng and its ingredients as well as the underlying mechanisms involved. For the purpose of this review, the following databases were consulted: the PubMed Database (https://pubmed.ncbi.nlm.nih.gov), Chinese National Knowledge Infrastructure (http://www.cnki.net), National Science and Technology Library (http://www.nstl.gov.cn/), Wanfang Data (http://www.wanfangdata.com.cn/) and the Web of Science Database (http://apps.webofknowledge.com/). Ginseng exhibits glucose-lowering effects in different diabetic animal models. In addition, Ginseng may prevent the development of diabetic complications, including liver, pancreas, adipose tissue, skeletal muscle, nephropathy, cardiomyopathy, retinopathy, atherosclerosis and others. The main ingredients of Ginseng include ginsenosides and polysaccharides. The underlying mechanisms whereby this herb exerts antidiabetic activities may be attributed to the regulation of multiple signaling pathways, including IRS1/PI3K/AKT, LKB1/AMPK/FoxO1, AGEs/RAGE, MAPK/ERK, NF-κB, PPARδ/STAT3, cAMP/PKA/CERB and HIF-1α/VEGF, etc. The pharmacokinetic profiles of ginsenosides provide valuable information on therapeutic efficacy of Ginseng in diabetes. Although Ginseng is well-tolerated, dietary consumption of this herb should follow the doctors' advice. Ginseng may offer an alternative strategy in protection against diabetes and its complications through the regulations of the multi-targets via various signaling pathways. Efforts to understand the underlying mechanisms with strictly-controlled animal models, combined with well-designed clinical trials and pharmacokinetic evaluation, will be important subjects of the further investigations and weigh in translational value of this herb in diabetes management.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
俏皮的采蓝完成签到,获得积分10
1秒前
姚瑞峰发布了新的文献求助10
2秒前
gloval发布了新的文献求助10
3秒前
小蘑菇发布了新的文献求助10
3秒前
3秒前
科研通AI6应助雪山飞狐采纳,获得10
4秒前
搜集达人应助狂野台灯采纳,获得10
6秒前
英姑应助deway采纳,获得10
6秒前
丘比特应助学术通zzz采纳,获得10
7秒前
欢呼妙柏发布了新的文献求助10
9秒前
9秒前
gloval完成签到,获得积分10
10秒前
10秒前
ywzwszl完成签到,获得积分10
11秒前
11秒前
机灵冬天完成签到,获得积分10
11秒前
幽默的以山完成签到,获得积分10
13秒前
14秒前
14秒前
Link发布了新的文献求助10
14秒前
小斌仔发布了新的文献求助30
15秒前
18秒前
简单发布了新的文献求助10
19秒前
tiam发布了新的文献求助10
20秒前
xzy998应助昏睡的秋灵采纳,获得20
20秒前
NexusExplorer应助昏睡的秋灵采纳,获得10
20秒前
lmz99588082完成签到,获得积分10
21秒前
雪山飞狐发布了新的文献求助10
21秒前
LUMO发布了新的文献求助10
22秒前
deway发布了新的文献求助10
23秒前
23秒前
英俊的铭应助张二十八采纳,获得10
24秒前
27秒前
在水一方应助Migrol采纳,获得10
27秒前
雪山飞狐完成签到,获得积分10
28秒前
云蓝发布了新的文献求助10
28秒前
28秒前
29秒前
领导范儿应助shtnice采纳,获得10
30秒前
曾经一笑完成签到,获得积分10
31秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
An overview of orchard cover crop management 1000
Rapid Review of Electrodiagnostic and Neuromuscular Medicine: A Must-Have Reference for Neurologists and Physiatrists 1000
二维材料在应力作用下的力学行为和层间耦合特性研究 600
基于3um sOl硅光平台的集成发射芯片关键器件研究 500
A review of Order Plesiosauria, and the description of a new, opalised pliosauroid, Leptocleidus demoscyllus, from the early cretaceous of Coober Pedy, South Australia 400
National standards & grade-level outcomes for K-12 physical education 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 4810502
求助须知:如何正确求助?哪些是违规求助? 4124019
关于积分的说明 12760257
捐赠科研通 3860163
什么是DOI,文献DOI怎么找? 2124908
邀请新用户注册赠送积分活动 1146616
关于科研通互助平台的介绍 1039991